Ridderheim M - Search Results

1

Two BRCA1-positive epithelial ovarian tumors with metastases to the central nervous system: a case report.

Koul A, Loman N, Malander S, Borg A, Ridderheim M. Koul A, et al. Among authors: ridderheim m. Gynecol Oncol. 2001 Mar;80(3):399-402. doi: 10.1006/gyno.2000.6085. Gynecol Oncol. 2001. PMID: 11263939

2

The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.

Malander S, Rambech E, Kristoffersson U, Halvarsson B, Ridderheim M, Borg A, Nilbert M. Malander S, et al. Among authors: ridderheim m. Gynecol Oncol. 2006 May;101(2):238-43. doi: 10.1016/j.ygyno.2005.10.029. Epub 2005 Dec 19. Gynecol Oncol. 2006. PMID: 16360201

3

One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.

Malander S, Ridderheim M, Måsbäck A, Loman N, Kristoffersson U, Olsson H, Nilbert M, Borg A. Malander S, et al. Among authors: ridderheim m. Eur J Cancer. 2004 Feb;40(3):422-8. doi: 10.1016/j.ejca.2003.09.016. Eur J Cancer. 2004. PMID: 14746861

4

BRCA1 and BRCA2 mutations in ovarian cancer: Covariation with specific cytogenetic features.

Koul A, Malander S, Loman N, Pejovic T, Heim S, Willen R, Johannsson O, Olsson H, Ridderheim M, Borg Å Å. Koul A, et al. Among authors: ridderheim m. Int J Gynecol Cancer. 2000 Jul;10(4):289-295. doi: 10.1046/j.1525-1438.2000.010004289.x. Int J Gynecol Cancer. 2000. PMID: 11240689

5

TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer.

Koul A, Bendahl PO, Borg A, Fernö M, Lidebring MF, Högberg T, Einarsson EL, Ridderheim M, Willén R. Koul A, et al. Among authors: ridderheim m. Int J Gynecol Cancer. 2002 Jul-Aug;12(4):362-71. doi: 10.1046/j.1525-1438.2002.01111.x. Int J Gynecol Cancer. 2002. PMID: 12144684

6

Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.

Lindgren P, Bäckström T, Mählck CG, Ridderheim M, Cajander S. Lindgren P, et al. Among authors: ridderheim m. Int J Oncol. 2001 Jul;19(1):31-8. Int J Oncol. 2001. PMID: 11408919

7

Peritoneal fluid and HCG influence on steroid production from ovarian tumor tissue, in vitro.

Ridderheim M, Mählck CG, Selstam G, Stendahl U, Bäckström T. Ridderheim M, et al. Anticancer Res. 1994 Sep-Oct;14(5A):1753-8. Anticancer Res. 1994. PMID: 7531411

8

Steroid production in different parts of malignant and benign ovarian tumors in vitro.

Ridderheim M, Mählck CG, Selstam G, Stendahl U, Bäckström T. Ridderheim M, et al. Cancer Res. 1993 May 15;53(10 Suppl):2309-12. Cancer Res. 1993. PMID: 8485717

9

A systematic overview of radiation therapy effects in ovarian cancer.

Einhorn N, Tropé C, Ridderheim M, Boman K, Sorbe B, Cavallin-Ståhl E. Einhorn N, et al. Among authors: ridderheim m. Acta Oncol. 2003;42(5-6):562-6. doi: 10.1080/02841860310014426. Acta Oncol. 2003. PMID: 14596514 Review.

10

First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG.

Lindemann K, Christensen RD, Vergote I, Stuart G, Izquierdo MA, Kærn J, Havsteen H, Eisenhauer E, Ridderheim M, Lopez AB, Hirte H, Aavall-Lundquvist E, Vrdoljak E, Green J, Kristensen GB. Lindemann K, et al. Among authors: ridderheim m. Ann Oncol. 2012 Oct;23(10):2613-2619. doi: 10.1093/annonc/mds060. Epub 2012 Apr 26. Ann Oncol. 2012. PMID: 22539562 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters